Piper Jaffray Downgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Ugly Stick Set to Tee-off on Endo Health (ENDP) Stock
January 4, 2013 10:26 AM ESTYesterday Endo Health Solutions (NASDAQ: ENDP) issued updated 2013 guidance that was below Street estimates.
Commenting on the development, analyst Elliot Wilbur said, "ENDP has taken the ugly stick to guidance once again . . . revised expectations capture not only the continued sluggish performance in... More
